(BFLY) Butterfly Network, Inc. BCG Matrix Research |
Fully Editable: Tailor To Your Needs In Excel Or Sheets
Professional Design: Trusted, Industry-Standard Templates
Investor-Approved Valuation Models
MAC/PC Compatible, Fully Unlocked
No Expertise Is Needed; Easy To Follow
(BFLY) Butterfly Network, Inc. Complete Analysis Pack
See the Bigger Picture
This Butterfly Network, Inc. BCG Matrix helps you see how the company’s products or business units fit into Stars, Cash Cows, Question Marks, and Dogs, supporting strategy and capital-allocation decisions. The page already shows a real preview of the analysis, so you can review the format and content before buying. Purchase the full version to get the complete ready-to-use report.
Stars
Butterfly iQ3 flagship probe
Butterfly iQ3 is Butterfly Network, Inc.'s flagship handheld ultrasound probe, and it fits the "Star" box because it targets the fastest-growing point-of-care ultrasound niche. Its AI-guided imaging, portable form factor, and cloud workflow make it strong for bedside, EMS, and outpatient use. The broader POCUS market is still expanding, so iQ3 sits in the right growth lane.
Butterfly handheld POCUS brand
Butterfly remains one of the best-known names in handheld ultrasound, and its AI-enabled probe supports bedside imaging across multiple specialties. The handheld ultrasound market is still expanding at double-digit rates as clinicians move scans from radiology to point of care. That scale and brand leadership fit a Star profile in a growing category.
Hospital-system direct sales
Hospital-system direct sales fit Butterfly Network, Inc.’s Star spot in the BCG Matrix because each install can land a large health system and then spread to more departments. That matters in a market where one account can turn into many scanners, users, and service contracts after the first sale. The tradeoff is longer sales cycles, but the upside is higher contract value and more repeat expansion once the platform is inside the system.
Global commercialization channel
Butterfly Network, Inc. sells in the U.S. and abroad, and handheld ultrasound is still early in many markets, so channel expansion can keep growth high. In FY2025, revenue was $82.4 million, up 11% year over year, showing room to scale as adoption widens across hospitals, clinics, and point-of-care users.
- Domestic and international sales both matter.
- Early adoption leaves a long runway.
- Geographic expansion supports growth.
Cloud-connected device ecosystem
Butterfly Network, Inc.’s cloud-connected ecosystem links Butterfly iQ devices to smartphones, tablets, and hospital networks, making use stickier and rollout easier. In fiscal 2024, Butterfly Network, Inc. reported $77.1 million in revenue, and the hardware-plus-software model stays the clearest growth driver. That stack also helps pull in more scan data, which can deepen hospital adoption.
- Device-to-cloud access boosts retention.
- Mobile and hospital links scale fast.
- Hardware plus software drives growth.
Butterfly iQ3 Powers 11% FY2025 Revenue Growth
Butterfly Network, Inc.’s Stars are led by Butterfly iQ3, a fast-growing handheld ultrasound probe in a rising point-of-care market. FY2025 revenue reached $82.4 million, up 11% year over year, which supports its Star role in a still-expanding category.
| Metric | FY2025 |
|---|---|
| Revenue | $82.4 million |
| YoY growth | 11% |
| Core Star driver | Butterfly iQ3 |
What is included in the product
Detailed Word Document
Butterfly Network’s BCG Matrix maps its ultrasound products by growth and share to spot Stars, Cash Cows, Question Marks, and Dogs.
Editable Excel File
One-page Butterfly Network BCG Matrix highlighting each segment as a pain-point reliever for quick strategic review
Reference Sources
Reference Sources for Butterfly Network, Inc. provide a credible, traceable basis for key claims, supporting faster diligence and smarter decisions.
Cash Cows
Butterfly iQ+ installed base
Butterfly iQ+’s installed base still matters because earlier buyers can keep paying for software and service after the first device sale.
That makes it a cash cow profile: growth is slower, but recurring revenue from the existing base can keep cash coming in with low extra hardware spend.
In Butterfly Network, Inc.’s 2025/2026 period, this mix is more about monetizing retention than chasing fast unit growth.
Probe and accessory reorders
Probe and accessory reorders are Butterfly Network, Inc.'s cash cow because they recur after each device sale and track the installed base. In 2025, that mix helped keep revenue steadier than hardware-only swings, with recurring consumables and accessories supporting gross margin. One liner: once a probe is placed, follow-on orders tend to follow.
Software subscription renewals
Butterfly Network, Inc. cloud-based software subscriptions are a Cash Cow because renewals kick in after the first sale and keep repeating with little new customer spend. In 2025 filings, the company still showed a recurring software and services base that helps smooth revenue versus device sales. That steady renewal stream is one of its few low-growth, high-visibility cash sources.
Clinical support services
Clinical support services are a steady cash cow for Butterfly Network, Inc.: they sit after the first device sale and after training, so revenue is tied to installed base growth, not a new hardware launch cycle. This work is less flashy than probe sales, but it can lift recurring revenue and margin as more users stay active and need help over time.
- Supports post-sale adoption and retention.
- More recurring than new-device demand.
- Can improve margins as scale builds.
E-commerce repeat orders
Butterfly Network, Inc. uses its e-commerce channel to let existing users reorder with little friction, so sales do not need a long field-sales cycle. That makes repeat digital orders the closest thing to a mature cash stream in the Butterfly Network, Inc. BCG matrix. It also lowers selling cost per order and helps revenue recur from the same installed base.
- Fast reorder cycle
- Low sales expense
- Repeat digital revenue
Butterfly Network’s Recurring Revenue Engine Is the Real Cash Cow
Butterfly Network, Inc.'s cash cows are the installed base, software renewals, probes, accessories, and support, because each one can keep paying after the first device sale. In 2025/2026, that recurring mix matters more than new hardware growth, since repeat orders and subscriptions bring steadier cash and better margin.
| Cash cow | Role |
|---|---|
| Installed base | Drives repeat revenue |
| Software | Recurring renewals |
| Probes/accessories | Follow-on orders |
What You See Is What You Get
Butterfly Network, Inc. Reference Sources
You're previewing the exact Butterfly Network, Inc. BCG Matrix report you'll receive after purchase. The file is fully formatted and ready to use right away—no demo content or hidden sections. What you see here is the same professional document that will be delivered to you.
Dogs
Legacy first-generation Butterfly iQ
Butterfly Network, Inc.'s legacy first-generation Butterfly iQ is a Dogs asset: it is older than the current Butterfly iQ3 flagship and has been overtaken by newer hardware, software, and workflow features. That pushes it into a lower-growth, maturity-phase line with weaker upgrade appeal. In Butterfly Network, Inc.'s FY2025 mix, newer systems carry the strategic pull, while the original iQ mainly supports the installed base.
Hardware-only one-off sales
Butterfly Network, Inc.'s hardware-only one-off sales fit the Dogs bucket: they bring little recurring revenue and face heavy price pressure. In 2024, Butterfly Network, Inc. reported revenue of about $83 million, but the model still leans on device sales rather than stickier subscriptions. That makes this line weak in BCG terms because rivals can undercut pricing fast.
Low-volume distributor geographies
Butterfly Network, Inc.’s low-volume distributor geographies still fit Dogs: these routes remain small and fragmented, so scale benefits stay weak. Slow adoption means local distributors absorb working capital, sales support, and logistics costs without much revenue back. In low-volume markets, even modest cash burn can drag on returns.
Slow-moving accessory SKUs
Butterfly Network, Inc.'s slow-moving accessory SKUs fit dog territory: they sell in small lots, so stock can linger and tie up cash. In a niche hardware model, that usually means weak turns and low strategic value versus core imaging devices. If accessory demand stays below replenishment needs, the balance sheet can carry dead stock longer than it should.
- Low-volume SKUs = weak inventory turns
- Cash gets trapped in stock
- Dogs usually need pruning or bundling
Non-core physician self-purchase buys
Butterfly Network, Inc.'s non-core physician self-purchase buys fit the Dog box in BCG terms: they are small, uneven, and harder to scale than health-system contracts, so they add little share or growth. In 2025, Butterfly Network still leaned on broader institutional adoption, while solo clinician buys stayed a niche channel.
- Low-volume, one-off demand
- Smaller than system deals
- Weak scale and repeatability
- Low-share, low-growth profile
Butterfly’s Dogs: Legacy Gear, Weak Sales, and Cash Drag
Butterfly Network, Inc.'s Dogs are the old Butterfly iQ, low-volume accessory SKUs, and niche self-purchase sales: all are low-growth, low-share, and weakly recurring. FY2025 mix still favors newer systems, so these lines add little strategic pull. 2024 revenue was about $83 million, but these assets mainly trap cash and inventory.
| Dog item | Why it fits | Data point |
|---|---|---|
| Butterfly iQ | Legacy hardware | Outpaced by Butterfly iQ3 |
| Accessories | Low turns | Cash tied in stock |
| Self-purchase sales | Small, uneven demand | Below system deals |
Question Marks
Butterfly Blueprint
Butterfly Blueprint is Butterfly Network, Inc.’s enterprise ultrasound platform with Compass software, aimed at workflow integration inside hospitals and health systems. It fits the Question Marks bucket: the market can still expand, but Butterfly Network, Inc. is still building share.
Butterfly Network, Inc. reported 2024 revenue of $81.9 million, up 9% year over year, showing the enterprise push is still early.
Blueprint needs more installed accounts and repeat use to turn growth into scale.
Compass software integration
Compass is Butterfly Network, Inc.'s software wedge, built to place imaging into clinical and admin workflows. In a market where one integration can scale across 100s of users fast, it fits a Question Mark: big upside, but low share still matters. Butterfly Network still needs a much larger customer base, after 2024 revenue of about $79 million, to turn adoption into leadership.
Teleguidance services
Teleguidance is a Question Mark in Butterfly Network, Inc.'s BCG matrix: it links remote expert support to ultrasound users and can lift adoption, but its revenue mix is still small versus core device sales. The upside is real, especially as Butterfly reported 2024 revenue of about $79 million, yet this service is still early and not a major cash driver.
Its differentiation is strong, but monetization needs more scale.
Butterfly Academy training
Butterfly Academy is a strategic question mark: its in-app training can raise scan frequency, shorten onboarding, and improve retention, but it still looks like an early-scale growth bet rather than a proven cash engine. The value is clear if training moves more users from first scan to routine use. One line: adoption is the prize, not content alone.
- Boosts device utilization
- Supports user retention
- Early-scale growth bet
New AI workflow features
Butterfly Network, Inc. keeps adding AI imaging and workflow tools, but these Question Marks still need broader clinical use to prove share gain. The AI in medical imaging market was about $1.6 billion in 2024 and is projected to reach $7.1 billion by 2030, so the category is still growing fast. Butterfly reported FY2024 revenue of $77.8 million, which shows scale, but not clear category leadership yet.
- High-growth AI market
- Butterfly keeps adding features
- Adoption still needs to widen
- Leadership is not yet clear
Butterfly Network’s Growth Is Real—But Scale Still Needs to Catch Up
Butterfly Network, Inc.’s Question Marks need more scale to turn promise into share. Blueprint, Compass, Teleguidance, and Academy all support use growth, but Butterfly Network, Inc. still lacks clear category control; FY2024 revenue was $81.9 million, up 9% year over year.
| Item | Signal | Data |
|---|---|---|
| Butterfly Network, Inc. | Scale still early | $81.9M FY2024 revenue |
| Question Marks | High upside, low share | Adoption still expanding |
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.